Apoptosis, UV-radiation, precancerosis and skin tumors;Apoptoza, UV-zračenje, prekanceroze i tumori kože

Acta Medica Croatica

Volumn 63, Issue SUPPL. 2, 2009, Pages 53-58

  Tomas, Davor ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Apoptosis; p53; Precancerous lesion; Skin tumor; UV radiation

Indexed keywords

PROTEIN P53;

ACTINIC KERATOSIS; APOPTOSIS; BOWEN DISEASE; CELL PROTECTION; DNA DAMAGE; GENE MUTATION; HUMAN; PRECANCER; RADIATION CARCINOGENESIS; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION; DRUG EFFECT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; SKIN; SKIN TUMOR; ULTRAVIOLET RADIATION;

APOPTOSIS; HUMANS; NEOPLASMS, RADIATION-INDUCED; PRECANCEROUS CONDITIONS; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 72849112711     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Haake AR, Roublevskaia I, Cooklis M. Apoptosis: a role in skin aging? Invest J Dermatol Symp Proc 1998; 3: 28-35.
2. Fuchs E. Epidermal differentiation and keratine gene expression. J Cell Sci Suppl 1993; 17: 197-208. (Pubitemid 24041299)
3. Sayama K, Hanakawa Y, Shirakata Y i sur. Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular inducer of keratinocyte differentiation. J Biol Chem 2001; 165: 2240-2250
4. Robitaille H, Proulx R, Robitaille K, Blouin R, Germain L. The mitogen-activated protein kinase kinase kinase dual leucine zipper-bearing kinase (DLK) act as a key regulator of keratinocyte terminal differentiation. J Biol Chem 2005; 280: 12732-12741 (Pubitemid 40491093)
5. Raj D, Brash DE, Grossman D. Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol 2006; 12: 243-257 (Pubitemid 43323157)
6. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SY. BCL2 protein is topographically restricted in tissue characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-6965 (Pubitemid 21915069)
7. Krajewski S, Krajewska M, Reed JC. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res 1996; 56: 2949-2955
8. Nickoloff BJ, Qin JZ, Chaturvedi V, Bacon P, Panella J, Denning MF. Life and death signaling pathways contibuting to skin cancer. J Invest Dermatol Symp Proc 200; 7: 27-35.
9. Polakowska RR, Piacentini M, Bartlett R, Goldsmith LA, Haake AR. Apoptosis in human skin development: Morphogenesis, periderm, and stem cells. Dev Dyn 1994; 112: 751-756
10. Sharov AA, Weiner L, Sharova TY i sur. Noggin overexpression inhibits eylid opening by alternating epidermal apoptosis and differentiation. EMBO J 2003; 22: 2992-3003.
11. Benassi L, Ottani D, Fantini F i sur. 1,25-dihydroxyvitamin D3, transforming growth factor beta1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes. J Invest Dermatol 1997; 109: 276-282
12. Qin JZ, Chaturvedi V, Denning MF i sur. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes. Oncogene 2002; 21: 2991-3002.
13. Benjamin CL, Ullrich SE, Kripke ML, Ananthaswamy HN. p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer. Photochem Photobiol 2008; 84: 55-62.
14. Gruijl FR, Rebel H. Early events in UV carcinogenesis - DNA damage, target cells and mutant p53 foci. Photochem Photobiol 2008; 84: 382-387
15. Cooke A, Johnson BE. Dose response, wavelength dependence and rate of excision of ultraviolet radiation-induced pyrimidine dimers in mouse skin DNA. Biochim Biophys Acta 1978; 517: 24-30. (Pubitemid 8254990)
16. Johnson BE. Formation of thymine containing dimers in skin exposed to ultraviolet radiation. Bull Cancer 1978; 65: 283-297
17. Smith ML, Ford JM, Hollander MC i sur. p53-mediated DNA repair responses to UV radiation: Studies of mouse cell laking p53, p21, and/or gadd45 genes. Mol Cell Biol 2000; 20: 3705-3714
18. Haris CC. p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 1993; 262: 1980-1981
19. Tokino T, Thiagalingam S, el-Deiry WS, Waldman T, Kinzler KW, Voglstein B. p53 tagged sites from human genomic DNA. Human Mol Genet 1994; 3: 1537-1542
20. Ko LJ, Prives C. p53: Puzzle and paradigm. Genes Dev 1996; 10: 1054-1072
21. Levine AJ. p53 the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331
22. Jin S, Levine AJ. The p53 functional circuit. J Cell Sci 2001; 114: 4139-4140
23. Benjamin CL, Ananthaswamy HN. p53 and the pathogenesis of skin cancer. Appl Pharmacol 2007; 224: 241-248
24. Brash DE, Rudolph JA, Simon JA i sur. A role for sunlight in skin cancer. UV-induced p53 mutation in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10124-10128
25. Ren ZP, Hedrum A, Ponten F i sur. Human epidermal cancer and accompanying precusors have identical p53 mutation different from p53 mutation in adjacent areas of clonally expanded non-neoplastic keratinocytes. Oncogene 1996; 12: 765-773
26. Kanjilal S, Strom SS, Clayman GL i sur. p53 mutation in nonmelanoma skin cancer of the head and neck: Molecular evidence for fiel cancerization. Cancer Res 1995; 55: 3604-3609
27. Brash DE, Zhang W, Grossman D, Takeuchi S. Colonization of adjacent stem cell compartments by mutant keratinocytes. Semin Cancer Biol 2005; 15: 97-102. (Pubitemid 40126240)
28. Zhang W, Remenyik E, Zelterman D, Brash DE, Wikonkal NM. Escaping stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc Natl Acad Sci USA 2001; 98: 13948-13953 (Pubitemid 33116004)
29. Berg RJW, van Kranen HJ, Rebel HG i sur. Early p53 alterations in mouse skin carcinogenesis by UV radiation: Immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc Natl Acad Sci USA 1996; 93: 274-278
30. Rebel H, Mosnier LO, Berg RJ i sur. Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: Kinetics of induction, effects of DNA repair deficiency, and p53 heterozigosity. Cancer Res 2001; 61: 977-983
31. Peus D, Vasa RA, Meves B, Beyerle A, Pittelkow MR. UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol 2000; 72: 135-140
32. Walterscheid JP, Ullrich SE, Nghiem DX. Platelete-activating factor, a molecular sensor for cellular damage, activates systemic immune supression. J Exp Med 2002; 195: 171-179
33. Oda K, Arakawa H, Tanaka T i sur. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102: 849-862
34. Mudgil AV, Segal N, Adriani F, Wang Y, Fuseing NE, Garlick JA. Ultraviolet B irradiation induces expansion of intraepithelial tumor cells in a tissue model of early cancer progression. J Invest Dermatol 2003; 121: 191-197 (Pubitemid 36900472)
35. Ouhtit A, Gorny A, Muller HK, Hill LL, Owen-Schaub L, Ananthaswamy HN. Loss of fas-ligand expression in mouse keratinocytes during UV carcinogenesis. Am J Pathol 2000; 157: 1975-1981
36. Stanimirović A, Čupić H, Bošnjak B, Krušlin B, Belicza M. Expression of p53, bcl-2 and growth hormone receptor in actinic keratosis, hypertrophic type. Arch Dermatol Res 2003; 295: 102-108 (Pubitemid 36960538)
37. Stanimirović A, Čupić H, Bošnjak B i sur. Expression of p53, bcl-2 and growth hormone receptor in atrophic type of actinic keratosis. J Dermatol Sci 2004; 34: 49-53. (Pubitemid 38134472)
38. Stanimirović A, Čupić H, BošnjakB, Tomas D, Krušlin B, Belicza M. TP53, Bcl2 and growth hormone expression in cutaneous squamous cell carcinoma. Acta Dermatovenerol Croat 2005; 13: 201-205
39. Tomas D, Krušlin B, Čupić H i sur. Correlation between Bcl-2 and Bax in atrophic and hypertrophic type of actinic keratosis. J Eur Acad Dermatol Venereol 2006; 20: 51-57
40. Moles JP, Moyret C, Guillot B i sur. p53 gene mutations in human epithelial skin cancers. Oncogene 1993; 8: 583-588
41. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutation in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878 (Pubitemid 24289415)
42. Stern RS, Bolshakov S, Natataj AJ, Ananthaswamy HN. p53 mutation in nonmelanom skin cancers occuring in psoralen ultraviolet a-treated patients: Evidence for heterogenity and field cancerization. J Invest Dermatol 2002; 119: 522-526 (Pubitemid 35001966)
43. Bolshakov S, Walker CM, Strom SS i sur. p53 mutation in human aggressive and nonaggressive basal and squamous cell carcinoma. Clin Cancer Res 2003; 9: 228-234 (Pubitemid 36109738)
44. Ziegler A, Jonason AS, Leffell DJ i sur. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 730-731
45. Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: A role for UVA in human skin carcinogenesis. Proc Natl Acad Sci USA 2004; 101: 4954-4959
46. Jiang W, Ananthaswamy HN, Muller HK, Kripke ML. p53 protects against skin cancer induction by UVB radiation. Oncogene 1999; 18: 4247-4253 (Pubitemid 29377855)
47. van Kranen HJ, Westerman A, Berg RJW i sur. Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice. Mut Res 2005; 571; 81-90.
48. Flores ER, Sengupta S, Miller JB i sur. Tumor predisposition in mice mutant for p63 and p57: Evidence for broader tumor supressor function for the p53 family. Cancer Cell 2005; 7: 363-373
49. Chen YK, Huse SS, Lin LM. Differential expression of p53, p63 and p73 proteins in human buccal squamous cell carcinoma. Clin Otolaryngol 2003; 28: 451-455
50. Hussein MR. Ultraviolet radiation and skin cancer: molecular mechanisms. J Cutan Pathol 2005; 32: 191-205. (Pubitemid 40278816)
51. Gelis C, Mavon A, Vicendo P. The contribution of calpains in the down-regulation of Mdm2 and p53 proteolysis in reconstructed human epidermis in response to solar irradiation. Photochem Photobiol 2005; 81: 975-872.
52. de Gruijl FR, van der Leun JC. Development of skin tumors in hairless mice after discontinuation of ultraviolet irradiation. Cancer Res 1991; 51: 979-984
53. Yoo GH, Piechocki MP, Oliver J i sur. Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer. Laryngoscope 2004; 114: 1871-1879
54. Xi S, Gooding WE, Grandis JR. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: Implication for cancer therapy. Oncogene 2005; 24: 970-979